doi:10.48130/ejcc-0026-0001

[1]

Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM-L, et al. 2019. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. The Lancet Oncology 20(11):1493−1505

doi: 10.1016/S1470-2045(19)30456-5

[2]

De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, et al. 2024. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. The Lancet Oncology 25(3):293−307

doi: 10.1016/S1470-2045(23)00646-0

[3]

van Dongen SI, de Nooijer K, Cramm JM, Francke AL, Oldenmenger WH, et al. 2020. Self-management of patients with advanced cancer: a systematic review of experiences and attitudes. Palliative Medicine 34(2):160−178

doi: 10.1177/0269216319883976

[4]

Foster C, Fenlon D. 2011. Recovery and self-management support following primary cancer treatment. British Journal of Cancer 105(1):S21−S28

doi: 10.1038/bjc.2011.419

[5]

Alsadah A, van Merode T, Alshammari R, Kleijnen J. 2020. A systematic literature review looking for the definition of treatment burden. Heliyon 6(4):e03641

doi: 10.1016/j.heliyon.2020.e03641

[6]

Eton DT, Elraiyah TA, Yost KJ, Ridgeway JL, Johnson A, et al. 2013. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Related Outcome Measures 4:7

doi: 10.2147/PROM.S44694

[7]

Eton DT, Ramalho de Oliveira D, Egginton JS, Ridgeway JL, Odell L, et al. 2012. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Related Outcome Measures 3:39−49

doi: 10.2147/PROM.S34681

[8]

Eton DT, Ridgeway JL, Egginton JS, Tiedje K, Linzer M, et al. 2015. Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions. Patient Related Outcome Measures 6:117−126

doi: 10.2147/PROM.S78955

[9]

Shippee ND, Shah ND, May CR, Mair FS, Montori VM. 2012. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. Journal of Clinical Epidemiology 65(10):1041−1051

doi: 10.1016/J.JCLINEPI.2012.05.005

[10]

Sav A, Salehi A, Mair FS, McMillan SS. 2017. Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature. BMC Medical Research Methodology 17(1):1−14

doi: 10.1186/S12874-017-0411-8

[11]

Sav A, McMillan SS, Akosile A. 2021. Burden of treatment among elderly patients with cancer: a scoping review. Healthcare 9(5):612

doi: 10.3390/healthcare9050612

[12]

Smith GL, Lopez-Olivo MA, Advani PG, Ning MS, Geng Y, et al. 2019. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. Journal of the National Comprehensive Cancer Network 17(10):1184−1192

doi: 10.6004/jnccn.2019.7305

[13]

de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araújo FS, et al. 2017. Measuring financial toxicity as a clinically relevant patient‐reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123(3):476−484

doi: 10.1002/cncr.30369

[14]

Nwozichi C, Omolabake S, Ojewale MO, Faremi F, Brotobor D, et al. 2024. Time toxicity in cancer care: A concept analysis using Walker and Avant's method. Asia-Pacific Journal of Oncology Nursing 11(12):100610

doi: 10.1016/j.apjon.2024.100610

[15]

Gupta A, Eisenhauer EA, Booth CM. 2022. The Time Toxicity of Cancer Treatment. Journal of Clinical Oncology 40(15):1611−1615

doi: 10.1200/JCO.21.02810

[16]

Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, et al. 2008. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U. S. Supportive Care in Cancer 16(7):791−801

doi: 10.1007/s00520-007-0380-2

[17]

Adam R, Nair R, Duncan LF, Yeoh E, Chan J, et al. 2023. Treatment burden in individuals living with and beyond cancer: A systematic review of qualitative literature. PLoS One 18(5):e0286308

doi: 10.1371/JOURNAL.PONE.0286308

[18]

Adam R, Duncan L, Maclennan SJ, Locock L. 2023. Treatment burden in survivors of prostate and colorectal cancers: a qualitative interview study. BMJ Open 13:e068997

doi: 10.1136/bmjopen-2022-068997

[19]

Eton DT, Yost KJ, Lai JS, Ridgeway JL, Egginton JS, et al. 2017. Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden. Quality of Life Research 26(2):489−503

doi: 10.1007/s11136-016-1397-0

[20]

Mair FS, May CR. 2014. Thinking about the burden of treatment. BMJ 349:g6680

doi: 10.1136/BMJ.G6680

[21]

Duncan P, Murphy M, Man MS, Chaplin K, Gaunt D, et al. 2018. Development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ). BMJ Open 8(4):e019413

doi: 10.1136/BMJOPEN-2017-019413

[22]

Tran VT, Harrington M, Montori VM, Barnes C, Wicks P, et al. 2014. Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform. BMC Medicine 12(1):109

doi: 10.1186/1741-7015-12-109

[23]

Adam R, Burton CD, Bond CM, Bruin M de, Murchie P. 2017. Can patient-reported measurements of pain be used to improve cancer pain management? A systematic review and meta-analysis. BMJ Supportive & Palliative Care 7(4):373−382

doi: 10.1136/bmjspcare-2016-001137

[24]

Balitsky AK, Rayner D, Britto J, Lionel AC, Ginsberg L, et al. 2024. Patient-reported outcome measures in cancer care: an updated systematic review and meta-analysis. JAMA Network Open 7(8):e2424793

doi: 10.1001/jamanetworkopen.2024.24793

[25]

Tran VT, Montori VM, Eton DT, Baruch D, Falissard B, et al. 2012. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Medicine 10(1):68

doi: 10.1186/1741-7015-10-68

[26]

Sheehan OC, Leff B, Ritchie CS, Garrigues SK, Li L, et al. 2019. A systematic literature review of the assessment of treatment burden experienced by patients and their caregivers. BMC Geriatrics 19(1):1−11

doi: 10.1186/s12877-019-1222-z

[27]

Arksey H, O'Malley L. 2005. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology 8(1):19−32

doi: 10.1080/1364557032000119616

[28]

Gallacher KI, Quinn T, Kidd L, Eton D, Dillon M, et al. 2019. Systematic review of patient-reported measures of treatment burden in stroke. BMJ Open 9(9):e029258

[29]

May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, et al. 2014. Rethinking the patient: Using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Services Research 14(1):1−11

doi: 10.1186/1472-6963-14-281

[30]

Gagnier JJ, Lai J, Mokkink LB, Terwee CB. 2021. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Quality of Life Research 30(8):2197−2218

doi: 10.1007/s11136-021-02822-4

[31]

Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, et al. 2010. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Medical Research Methodology 10(1):22

doi: 10.1186/1471-2288-10-22

[32]

Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, et al. 2010. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of Clinical Epidemiology 63(7):737−745

doi: 10.1016/j.jclinepi.2010.02.006

[33]

Husebø AML, Dalen I, Søreide JA, Bru E, Richardson A. 2022. Cancer‐related fatigue and treatment burden in surgically treated colorectal cancer patients – A cross‐sectional study. Journal of Clinical Nursing 31(21-22):3089−3101

doi: 10.1111/jocn.16135

[34]

Husebø AML, Dalen I, Richardson A, Bru E, Søreide JA. 2021. Factors influencing treatment burden in colorectal cancer patients undergoing curative surgery: a cross‐sectional study. European Journal of Cancer Care 30(5):e13437

doi: 10.1111/ecc.13437

[35]

Aghdam N, Pepin A, Carrasquilla M, Johnson C, Danner M, et al. 2020. Self-reported burden in elderly patients with localized prostate cancer treated with Stereotactic Body Radiation Therapy (SBRT). Frontiers in Oncology 9:1528

doi: 10.3389/fonc.2019.01528

[36]

Anderson RT, Eton DT, Camacho FT, Kennedy EM, Brenin CM, et al. 2021. Impact of comorbidities and treatment burden on general well-being among women's cancer survivors. Journal of Patient-Reported Outcomes 5(1):2

doi: 10.1186/s41687-020-00264-z

[37]

Beeler WH, Bellile EL, Casper KA, Jaworski E, Burger NJ, et al. 2020. Patient-reported financial toxicity and adverse medical consequences in head and neck cancer. Oral Oncology 101:104521

doi: 10.1016/j.oraloncology.2019.104521

[38]

Stone BV, Laviana AA, Luckenbaugh AN, Huang LC, Zhao Z, et al. 2021. Patient-reported financial toxicity associated with contemporary treatment for localized prostate cancer. Journal of Urology 205(3):761−768

doi: 10.1097/JU.0000000000001423

[39]

Kent EE, Forsythe LP, Yabroff KR, Weaver KE, De Moor JS, et al. 2013. Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care? Cancer 119(20):3710−3717

doi: 10.1002/cncr.28262

[40]

Haider SA, Asmaro K, Kalkanis SN, Lee IY, Bazydlo M, et al. 2020. The economic impact of glioma survivorship: the cost of care from a patient perspective. Neurology 95(11):e1575−e1581

doi: 10.1212/WNL.0000000000010263

[41]

Yucel A, Skalicky A, Eseyin OR, Yucel E, Belani R, et al. 2021. Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating Factor (SEQ-G-CSF). Journal of Patient-Reported Outcomes 5(1):10

doi: 10.1186/s41687-020-00277-8

[42]

Greenup RA, Rushing C, Fish L, Campbell BM, Tolnitch L, et al. 2019. Financial costs and burden related to decisions for breast cancer surgery. Journal of Oncology Practice 15(8):e666−e676

doi: 10.1200/JOP.18.00796

[43]

Saoud RM, Andolfi C, Aizen J, Wymer K, Burg M, et al. 2021. Impact of non–guideline-directed care on quality of life in testicular cancer survivors. European Urology Focus 7(5):1137−1142

doi: 10.1016/j.euf.2020.10.005

[44]

Rifkin RM, Bell JA, DasMahapatra P, Hoole M, Lowe M, et al. 2020. Treatment satisfaction and burden of illness in patients with newly diagnosed multiple myeloma. PharmacoEconomics - Open 4(3):473−483

doi: 10.1007/s41669-019-00184-9

[45]

Philp L, Alimena S, Ferris W, Saini A, Bregar AJ, et al. 2022. Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer. Gynecologic Oncology 164(2):421−427

doi: 10.1016/j.ygyno.2021.12.017

[46]

Eton DT, Anderson RT, Cohn WF, Kennedy EM, St. Sauver JL, et al. 2019. Risk factors for poor health-related quality of life in cancer survivors with multiple chronic conditions: exploring the role of treatment burden as a mediator. Patient Related Outcome Measures 10:89−99

doi: 10.2147/PROM.S191480

[47]

Bath NM, Sarna A, Palettas M, Monsour C, Stevens L, et al. 2023. Characterizing treatment burden during neoadjuvant therapy for patients with gastrointestinal cancer: a mixed methods analysis. Journal of Surgical Oncology 128(2):393−401

doi: 10.1002/jso.27288

[48]

Garg T, Frank K, Johns A, Rabinowitz K, Danella JF, et al. 2024. Geriatric assessment-derived deficit accumulation and patient-reported treatment burden in older adults with bladder cancer. Journal of the American Geriatrics Society 72(2):490−502

doi: 10.1111/jgs.18676

[49]

Kircher S, Duan F, An N, Gareen IF, Sicks JD, et al. 2024. Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer. JAMA Network Open 7(1):e2350844

doi: 10.1001/jamanetworkopen.2023.50844

[50]

Myers A, Ristau B, Mossanen M, Tyson MD, Chisolm S, et al. 2024. Patient reported treatment burden and attitudes towards in-home intravesical therapy among patients with bladder cancer. Urologic Oncology 42(2):29. e17−29. e22

doi: 10.1016/j.urolonc.2023.09.006

[51]

Smedsland SK, Falk RS, Reinertsen KV, Kiserud CE, Brekke M, et al. 2024. Burden of late effects in a nationwide sample of long-term breast cancer survivors. Cancer 130(1):140−149

doi: 10.1002/cncr.35019

[52]

Karimzadeh A, Soeiro P, Feuerecker B, Hecker CS, Knorr K, et al. 2023. Improved quality of life in metastatic castration-resistant prostate cancer patients receiving consecutive cycles of ¹⁷⁷Lu-PSMA I&T. Journal of Nuclear Medicine 64(11):1765−1771

doi: 10.2967/jnumed.123.265878

[53]

Xiao T, Zhong H, Xiao R, Chen T, Li L, et al. 2024. Profiles of financial toxicity and influencing factors among cancer patients: a latent profile analysis. Research in Social & Administrative Pharmacy 20(2):137−144

doi: 10.1016/j.sapharm.2023.10.010

[54]

Morris JE, Roderick PJ, Harris S, Yao G, Crowe S, et al. 2021. Treatment burden for patients with multimorbidity: cross-sectional study with exploration of a single-item measure. British Journal of General Practice 71(706):e381−e390

doi: 10.3399/BJGP.2020.0883

[55]

Hounkpatin HO, Roderick P, Harris S, Morris JE, Smith D, et al. 2022. Change in treatment burden among people with multimorbidity: a follow-up survey. British Journal of General Practice 72(724):e816−e824

doi: 10.3399/BJGP.2022.0103

[56]

Braun I, Friedrich M, Morgenstern L, Sender A, Geue K, et al. 2023. Changes, challenges and support in work, education and finances of adolescent and young adult (AYA) cancer survivors: A qualitative study. European Journal of Oncology Nursing 64:102329

doi: 10.1016/j.ejon.2023.102329

[57]

Sav A, Whitty JA, McMillan SS, Kendall E, Kelly F, et al. 2016. Treatment burden and chronic illness: who is at most risk? The Patient − Patient-Centered Outcomes Research 9(6):559−569

doi: 10.1007/s40271-016-0175-y

[58]

Demain S, Gonçalves AC, Areia C, Oliveira R, Marcos AJ, et al. 2015. Living with, managing and minimising treatment burden in long term conditions: a systematic review of qualitative research. PLOS ONE 10(5):e0125457

doi: 10.1371/journal.pone.0125457

[59]

Duncan P, Gamlin C, McCahon D, Gaunt D, Ashfaq B, et al. 2026. Associations between treatment burden, socio-demographics, clinical factors and use of medicines in adults with polypharmacy: a cross-sectional study. Journal of Multimorbidity and Comorbidity 16:1−13

doi: 10.1177/26335565261420367

[60]

Hughes L, Taylor RM, Beckett AE, Lindner OC, Martin A, et al. 2024. The emotional impact of a cancer diagnosis: a qualitative study of adolescent and young adult experience. Cancers 16(7):1332

doi: 10.3390/cancers16071332

[61]

Lie NK, Larsen TMB, Hauken MA. 2018. Coping with changes and uncertainty: a qualitative study of young adult cancer patients' challenges and coping strategies during treatment. European Journal of Cancer Care 27:e12743

doi: 10.1111/ecc.12743

[62]

Al-mansouri A, Al-Ali FS, Hamad AI, Mohamed Ibrahim MI, Kheir N, et al. 2021. Assessment of treatment burden and its impact on quality of life in dialysis-dependent and pre-dialysis chronic kidney disease patients. Research in Social and Administrative Pharmacy 17(11):1937−1944

doi: 10.1016/j.sapharm.2021.02.010

[63]

Qu W, Wang X, Zhang S, Wei H, Zhou P, et al. 2025. Factors related to the treatment burden of patients with coronary heart disease: a cross-sectional study. Heart & Lung 70:141−146

doi: 10.1016/j.hrtlng.2024.11.019

[64]

Hardman R, Begg S, Spelten E. 2022. Exploring the ability of self-report measures to identify risk of high treatment burden in chronic disease patients: a cross-sectional study. BMC Public Health 22(1):163

doi: 10.1186/s12889-022-12579-1

[65]

Tahsin F, Steele Gray C, Shaw J, Shachak A. 2024. Exploring the relationship between telehealth utilization and treatment burden among patients with chronic conditions: a cross-sectional study in Ontario, Canada. PLOS Digital Health 3(10):e0000610

doi: 10.1371/journal.pdig.0000610

[66]

Koros H, Nolte E, Kamano J, Mugo R, Murphy A, et al. 2023. Understanding the treatment burden of people with chronic conditions in Kenya: a cross-sectional analysis using the Patient Experience with Treatment and Self-Management (PETS) questionnaire. PLoS Global Public Health 3:e0001407

doi: 10.1371/journal.pgph.0001407

[67]

Sim SZ, Ding SY, Lew JK, Lee ES. 2024. Understanding treatment burden in adults with multimorbidity in the Singapore primary care setting: an exploratory study using the Multimorbidity Treatment Burden Questionnaire. Annals of the Academy of Medicine, Singapore 53(5):318−320

doi: 10.47102/annals-acadmedsg.2023229

[68]

Vasiliauskienė O, Vasiliauskas D, Duncan P, Kontrimiene A, Jaruseviciene L, et al. 2023. Validation of the Lithuanian multimorbidity treatment burden questionnaire (MTBQ) and its association with primary care patient characteristics. The European Journal of General Practice 29(1):2284257

doi: 10.1080/13814788.2023.2284257

[69]

Gebreyohannes EA, Gebresillassie BM, Mulugeta F, Dessu E, Abebe TB. 2023. Treatment burden and health-related quality of life of patients with multimorbidity: a cross-sectional study. Quality of Life Research 32(11):3269−3277

doi: 10.1007/s11136-023-03473-3

[70]

Ahmed I, Altayeb L. 2025. Eight in ten multimorbid patients experience high treatment burden: a cross-sectional survey in an outpatient setting. Sudan Journal of Medical Sciences 20(1):50−60

doi: 10.18502/sjms.v20i1.14340

[71]

Austin RC, Schoonhoven L, Koutra V, Richardson A, Kalra PR, et al. 2022. SYMptoms in chronic heart failure imPACT on burden of treatment (SYMPACT): a cross‐sectional survey. ESC Heart Failure 9(4):2279−2290

doi: 10.1002/ehf2.13904

[72]

Chaplin K, Bower P, Man MS, Brookes ST, Gaunt D, et al. 2018. Understanding usual care for patients with multimorbidity: baseline data from a cluster-randomised trial of the 3D intervention in primary care. BMJ Open 8(8):e019845

doi: 10.1136/bmjopen-2017-019845

[73]

McCullough AR, Tunney MM, Quittner AL, Elborn JS, Bradley JM, et al. 2014. Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulmonary Medicine 14(1):107

doi: 10.1186/1471-2466-14-107

[74]

Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, et al. 2019. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. JNCI: Journal of the National Cancer Institute 111(11):1120−1130

doi: 10.1093/jnci/djz089

[75]

Manne S, Nekhlyudov L. 2024. Introduction: The history of cancer survivorship programs in the USA: progress, challenges, and opportunities. Journal of Cancer Survivorship 18(1):1−4

doi: 10.1007/s11764-023-01528-5

[76]

Adam R, Duncan L, MacLennan S, Locock L, Kiltie AE, et al. 2025. Co-design of the structured personalised assessment for reviews after cancer (SPARC) intervention. Health Expectations 28(1):e70174

doi: 10.1111/hex.70174

[77]

Murray SA, Kendall M, Boyd K, Sheikh A. 2005. Illness trajectories and palliative care. BMJ  330:1007−1011

doi: 10.1136/bmj.330.7498.1007

[78]

Murray SA, Kendall M, Grant E, Boyd K, Barclay S, et al. 2007. Patterns of social, psychological, and spiritual decline toward the end of life in lung cancer and heart failure. Journal of Pain and Symptom Management 34(4):393−402

doi: 10.1016/j.jpainsymman.2006.12.009

[79]

Carter CR, Maki J, Ackermann N, Waters EA. 2023. Inclusive recruitment strategies to maximize sociodemographic diversity among participants: a St. Louis case study. MDM Policy & Practice 8(1):1−11

doi: 10.1177/23814683231183646

[80]

Eton DT, Yost KJ, Ridgeway JL, Bucknell B, Wambua M, et al. 2024. Development and acceptability of PETS-Now, an electronic point-of-care tool to monitor treatment burden in patients with multiple chronic conditions: a multi-method study. BMC Primary Care 25(1):77

doi: 10.1186/s12875-024-02316-5

[81]

Lesage A, Leclère B, Moret L, Le Glatin C. 2021. Decreasing patient-reported burden of treatment: a systematic review of quantitative interventional studies. PLoS One 16:e0245112

doi: 10.1371/JOURNAL.PONE.0245112

[82]

Polus M, Keikhosrokiani P, Korhonen O, Behutiye W, Isomursu M. 2024. Impact of digital interventions on the treatment burden of patients with chronic conditions: protocol for a systematic review. JMIR Research Protocols 13:e54833

doi: 10.2196/54833

[83]

Chen M, Wu VS, Falk D, Cheatham C, Cullen J, et al. 2024. Patient navigation in cancer treatment: a systematic review. Current Oncology Reports 26(5):504−537

doi: 10.1007/s11912-024-01514-9